Summary
The U.S. FDA has announced a nationwide recall of certain bottles of Children's Ibuprofen due to reports of a foreign substance in the medication. The recall affects two specific lots of the product, and parents are advised to stop using it and contact a doctor if they have concerns.
Key Facts
- The FDA issued a recall for Children's Ibuprofen Oral Suspension, 100 mg per 5 mL, in 4-fluid-ounce bottles.
- The recall involves a substance described as a gel-like mass and black particles found in the medication.
- The affected lots are numbered 7261973A and 7261974A, with an expiration date of January 31, 2027.
- A total of 89,592 bottles have been recalled, distributed across the United States.
- Strides Pharma Inc. is the company that distributed the affected products.
- The FDA classified this recall as Class II, indicating that it may lead to temporary health issues.
- Consumers are advised to check for the lot numbers and stop using the affected products.
- Parents should contact healthcare providers if they have health concerns regarding the recalled medication.
